Summary

The bone health supplements market was valued at $13,745.5 million in 2024 and is estimated to reach $23,081.56 million by 2034, exhibiting a CAGR of 5.3% from 2025 to 2034.
Dietary products that offer essential nutrients to improve bone strength and bone density are called bone health supplements. These supplements help manage conditions such as arthritis, osteoporosis, and age-related bone loss. These supplements also maintain the overall skeletal health of the patient.
Increase in prevalence of bone-related disorders, rise in health awareness, and surge in aging population boost the growth of the bone health supplements market. These supplements are available in the form of softgels, gummies, and others, which increase their popularity among the end users. Furthermore, changes in lifestyle and poor dietary habits reduce bone strength which results in the rise in demand of bone health supplements, thus boosting the market growth.
However, bone health supplements are available at a higher cost in the market. Also, there is an increase in the availability of counterfeit products in the market. These factors limit the growth of the market. There is an increase in awareness of preventive healthcare among the people. This increases the adoption of bone health supplements to strengthen bone strength. In addition, there is also an increase in the participation of sports and fitness activities, which also increases the consumption of these supplements.

Segment Review
The bone health supplements market is segmented into type, dosage form, distribution channel, and region. On the basis of type, it is divided into vitamins, calcium, collagen, omega-3, glucosamine, and others. On the basis of dosage form, the market is segregated into tablets, capsules, powders, and others. the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Key Takeaways
On the basis of type, the calcium segment accounted for the largest share in terms of revenue in 2024
On the basis of dosage form, the tablets segment accounted for the largest share in terms of revenue in 2024.
On the basis of distribution channel, the supermarkets/hypermarkets segment accounted for the largest share in terms of revenue in 2024
On the basis of region, North America dominated the market share in 2024
Competitive Analysis
The major companies profiled in the report include Amway, Bayer AG, Abbott Laboratories, Haleon Plc., Nestlé S.A., Nutramax Laboratories, Inc., Kirin Holdings (Blackmores), Herbalife, Otsuka Holdings Co. Ltd. (Pharmavite), and NOW Foods. The key players operating in the market have adopted product launch as their key strategies to expand their product portfolio.

Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the bone health supplement market analysis from 2024 to 2034 to identify the prevailing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the bone health supplement market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global bone health supplement market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles

Key Market Segments
By Type
● Vitamins
● Calcium
● Collagen
● Omega-3
● Glucosamine
● Others

By Dosage Form
● Tablets
● Capsules
● Powder
● Others

By Distribution Channel
● Pharmacies and Drug Stores
● Supermarkets or Hypermarkets
● Online Providers
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ NOW Foods
○ Haleon plc
○ Abbott Laboratories
○ Bayer AG
○ Amway Corp.
○ Nestle S.A.
○ Kirin Holdings
○ Nutramax Laboratories, Inc.
○ Herbalife
○ Otsuka Holdings Co., Ltd.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION

1.1. Report description


1.2. Key market segments


1.3. Key benefits to the stakeholders


1.4. Research methodology

1.4.1. Primary research


1.4.2. Secondary research


1.4.3. Analyst tools and models


CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective


CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope


3.2. Key findings

3.2.1. Top impacting factors


3.2.2. Top investment pockets


3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers

3.3.2. Moderate threat of new entrants

3.3.3. Moderate threat of substitutes

3.3.4. Moderate intensity of rivalry

3.3.5. Moderate bargaining power of buyers

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rising Geriatric Population and Osteoporosis Burden

3.4.1.2. Rise in Preventive Healthcare and Nutritional Deficiencies

3.4.1.3. Product Innovation and Distribution Expansion

3.4.2. Restraints

3.4.2.1. Safety Concerns and Side Effects

3.4.3. Opportunities

3.4.3.1. Growth Opportunities in Emerging Markets

CHAPTER 4: BONE HEALTH SUPPLEMENTS MARKET, BY TYPE
4.1. Overview

4.1.1. Market size and forecast

4.2. Vitamins
4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Calcium
4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Collagen
4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Omega-3
4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

4.6. Glucosamine
4.6.1. Key market trends, growth factors and opportunities

4.6.2. Market size and forecast, by region

4.6.3. Market share analysis by country

4.7. Others
4.7.1. Key market trends, growth factors and opportunities

4.7.2. Market size and forecast, by region

4.7.3. Market share analysis by country

CHAPTER 5: BONE HEALTH SUPPLEMENTS MARKET, BY DOSAGE FORM
5.1. Overview

5.1.1. Market size and forecast

5.2. Tablets
5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Capsules
5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Powder
5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Others
5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

CHAPTER 6: BONE HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview

6.1.1. Market size and forecast

6.2. Pharmacies and Drug Stores
6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Supermarkets or Hypermarkets
6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Online Providers
6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

6.5. Others
6.5.1. Key market trends, growth factors and opportunities

6.5.2. Market size and forecast, by region

6.5.3. Market share analysis by country

CHAPTER 7: BONE HEALTH SUPPLEMENTS MARKET, BY REGION
7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America
7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by Type

7.2.3. Market size and forecast, by Dosage Form

7.2.4. Market size and forecast, by Distribution Channel

7.2.5. Market size and forecast, by country
7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Dosage Form
7.2.5.1.3. Market size and forecast, by Distribution Channel

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Dosage Form
7.2.5.2.3. Market size and forecast, by Distribution Channel

7.2.5.3. Mexico

7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Dosage Form
7.2.5.3.3. Market size and forecast, by Distribution Channel

7.3. Europe
7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by Type

7.3.3. Market size and forecast, by Dosage Form

7.3.4. Market size and forecast, by Distribution Channel

7.3.5. Market size and forecast, by country
7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Dosage Form
7.3.5.1.3. Market size and forecast, by Distribution Channel

7.3.5.2. France

7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Dosage Form
7.3.5.2.3. Market size and forecast, by Distribution Channel

7.3.5.3. UK

7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Dosage Form
7.3.5.3.3. Market size and forecast, by Distribution Channel

7.3.5.4. Italy

7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Dosage Form
7.3.5.4.3. Market size and forecast, by Distribution Channel

7.3.5.5. Spain

7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Dosage Form
7.3.5.5.3. Market size and forecast, by Distribution Channel

7.3.5.6. Rest of Europe

7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Dosage Form
7.3.5.6.3. Market size and forecast, by Distribution Channel

7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by Type

7.4.3. Market size and forecast, by Dosage Form

7.4.4. Market size and forecast, by Distribution Channel

7.4.5. Market size and forecast, by country
7.4.5.1. Japan

7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Dosage Form
7.4.5.1.3. Market size and forecast, by Distribution Channel

7.4.5.2. China

7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Dosage Form
7.4.5.2.3. Market size and forecast, by Distribution Channel

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Dosage Form
7.4.5.3.3. Market size and forecast, by Distribution Channel

7.4.5.4. Australia

7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Dosage Form
7.4.5.4.3. Market size and forecast, by Distribution Channel

7.4.5.5. South Korea

7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Dosage Form
7.4.5.5.3. Market size and forecast, by Distribution Channel

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Dosage Form
7.4.5.6.3. Market size and forecast, by Distribution Channel

7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities

7.5.2. Market size and forecast, by Type

7.5.3. Market size and forecast, by Dosage Form

7.5.4. Market size and forecast, by Distribution Channel

7.5.5. Market size and forecast, by country
7.5.5.1. Brazil

7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Dosage Form
7.5.5.1.3. Market size and forecast, by Distribution Channel

7.5.5.2. Saudi Arabia

7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Dosage Form
7.5.5.2.3. Market size and forecast, by Distribution Channel

7.5.5.3. South Africa

7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Dosage Form
7.5.5.3.3. Market size and forecast, by Distribution Channel

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Dosage Form
7.5.5.4.3. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction

8.2. Top winning strategies

8.3. Product mapping of top 10 player

8.4. Competitive dashboard

8.5. Competitive heatmap

8.6. Top player positioning, 2024

CHAPTER 9: COMPANY PROFILES
9.1. Amway Corp.
9.1.1. Company overview

9.1.2. Key executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.1.6. Key strategic moves and developments

9.2. Bayer AG
9.2.1. Company overview

9.2.2. Key executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.2.6. Business performance

9.3. Abbott Laboratories
9.3.1. Company overview

9.3.2. Key executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.4. Nutramax Laboratories, Inc.
9.4.1. Company overview

9.4.2. Key executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. Haleon plc
9.5.1. Company overview

9.5.2. Key executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.5.6. Business performance

9.6. Herbalife
9.6.1. Company overview

9.6.2. Key executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.6. Business performance

9.7. NOW Foods
9.7.1. Company overview

9.7.2. Key executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. Kirin Holdings
9.8.1. Company overview

9.8.2. Key executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.9. Otsuka Holdings Co., Ltd.
9.9.1. Company overview

9.9.2. Key executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. Nestle S.A.
9.10.1. Company overview

9.10.2. Key executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performance

9.10.7. Key strategic moves and developments